Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2024-12-17 12:56:12

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

AI system based on Moorfields model tackles eye health inequalities in outback Australia

A mobile retinal camera with fully integrated artificial intelligence (AI) is being deployed in remote Western Australia in an effort to prevent rural and Indigenous Australians going blind from Diabetic […]

New Associate WAEH Member: Shanghai Eye Disease Prevention and Treatment Center!

The World Association of Eye Hospitals warmly congratulates Shanghai Eye Disease Prevention and Treatment Center from China with their associate membership of the WAEH! We are looking forward to the […]

News from our member L V Prasad Eye Institute

Tech Transfer In September this year, we licenced GraCS, our in-house grant management portal, to the Agriculture and Forestry University (AFU) in Nepal through the LVPEI Technology Transfer Office (TTO). […]

Upcoming Chair of the Executive Board of the WAEH 2025

At the 18th Annual Meeting in China, the board of the World Association of Eye Hospitals (WAEH) proudly announced that Christine Nelson, M.D., from the Kellogg Eye Center in Ann […]

Short Recap 18th Annual WAEH Meeting

WAEH 18th Annual Meeting Thank you for hosting the 18th Annual WAEH Meeting WAEH 18th Annual Meeting Group Photo at AIER Eye Hospital Group, Changsha WAEH 18th Annual Meeting Thank […]